Liraglutide studies: 1,219 papers with results
Page 22 of 25
- IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.
Miller E · Diabetes, obesity & metabolism · 2019
Not a test of Liraglutide alone · 5 results
- Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
Kawaguchi Y · Advances in therapy · 2022
Not a test of Liraglutide alone · 5 results
- Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study.
Oe Y · Journal of diabetes research · 2022
Not a test of Liraglutide alone · 5 results
- A Systematic Review Identifying Critical Evidence Gaps in Reporting Dietary Change in Randomized Controlled Trials Prescribing Liraglutide, Semaglutide, or Tirzepatide.
Jansson AK · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
Not a test of Liraglutide alone · 15 results
- Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial.
Punthakee Z · Diabetes, obesity & metabolism · 2024
Not a test of Liraglutide alone · 5 results
- Comparison of insulin degludec (IDeg)/insulin Aspart (IAsp) co-formulation therapy twice-daily with free combination of GLP-1 receptor agonist liraglutide plus insulin degludec in Tochigi: IDEAL Trial.
Aso Y · International journal of clinical practice · 2021
Not a test of Liraglutide alone · 5 results
- GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling.
Gupta AK · Science progress · 2026
Not a test of Liraglutide alone · 19 results
- Combination of metformin with liraglutide in treating HAIR-AN syndrome in children: A case report and literature review.
Li R · Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
Not a test of Liraglutide alone · 5 results
- Systemic Pharmacokinetic Principles of Therapeutic Peptides.
Nordell P · Clinical pharmacokinetics · 2026
Not a test of Liraglutide alone · 22 results
- Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications.
Rahman E · Toxicon : official journal of the International Society on Toxinology · 2026
Not a test of Liraglutide alone · 20 results
- Clinical studies on anti-obesity medications in Arab countries.
AlOtaibi HF · Saudi medical journal · 2025
Not a test of Liraglutide alone · 5 results
- Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials.
Al Yami MS · Heart, lung & circulation · 2018
Not a test of Liraglutide alone · 5 results
- The Effect of GLP-1 Receptor Agonists on Alanine Aminotransferase and Other Metabolic Parameters in Youths with Obesity: A Systematic Review and Meta-Analysis.
Hertzer LA · Childhood obesity (Print) · 2026
Not a test of Liraglutide alone · 10 results
- A case report of postoperative poor drainage of perianal abscess in an obese diabetic patient treated with comprehensive therapy.
Li F · Journal of surgical case reports · 2026
Not a test of Liraglutide alone · 5 results
- Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.
Qi H · PeerJ · 2026
Not a test of Liraglutide alone · 17 results
- Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Jensen AB · Obesity surgery · 2023
Not a test of Liraglutide alone · 8 results
- Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.
Zhou J · BMC medicine · 2024
Not a test of Liraglutide alone · 12 results
- Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials.
Nreu B · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2020
Not a test of Liraglutide alone · 8 results
- Clinical outcomes associated with anti-obesity medications in real-world practice: A systematic literature review.
Ahmad NN · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
Not a test of Liraglutide alone · 4 results
- Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial.
Persson F · Diabetes care · 2021
Not a test of Liraglutide alone · 4 results
- The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review.
Brunchmann A · Physiology & behavior · 2019
Not a test of Liraglutide alone · 4 results
- The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review.
Ng NBH · Clinical endocrinology · 2022
Not a test of Liraglutide alone · 4 results
- Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.
Usui R · Journal of diabetes investigation · 2018
Not a test of Liraglutide alone · 4 results
- Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
Ferjan S · Metabolic syndrome and related disorders · 2017
Not a test of Liraglutide alone · 4 results
- The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour.
de Boer SA · International journal of clinical pharmacy · 2016
Not a test of Liraglutide alone · 4 results
- Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial.
Pantalone KM · JAMA network open · 2021
Not a test of Liraglutide alone · 4 results
- Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes.
Matza LS · Current medical research and opinion · 2018
Not a test of Liraglutide alone · 8 results
- Preserved pharmacokinetic exposure and distinct glycemic effects of insulin degludec and liraglutide in IDegLira, a fixed-ratio combination therapy.
Kapitza C · Journal of clinical pharmacology · 2015
Not a test of Liraglutide alone · 4 results
- Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK.
Hall GC · Diabetic medicine : a journal of the British Diabetic Association · 2013
Not a test of Liraglutide alone · 4 results
- The effects of weight-lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta-analysis of randomized controlled trials.
Jobanputra R · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2023
Not a test of Liraglutide alone · 8 results
- Comparison between insulin degludec/liraglutide treatment and insulin glargine/lixisenatide treatment in type 2 diabetes: a systematic review and meta-analysis.
Cai X · Expert opinion on pharmacotherapy · 2017
Not a test of Liraglutide alone · 4 results
- Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.
Lee WC · Current medical research and opinion · 2011
Not a test of Liraglutide alone · 4 results
- IDegLira fixed-ratio combination in the real world: a retrospective observational single-center Italian experience.
Di Loreto C · European review for medical and pharmacological sciences · 2020
Not a test of Liraglutide alone · 4 results
- Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia.
Lasalvia P · Value in health regional issues · 2017
Not a test of Liraglutide alone · 10 results
- Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Kaneko K · BMC endocrine disorders · 2019
Not a test of Liraglutide alone · 4 results
- Comparison of different protein precipitation and solid-phase extraction protocols for the study of the catabolism of peptide drugs by LC-HRMS.
Esposito S · Journal of peptide science : an official publication of the European Peptide Society · 2020
Not a test of Liraglutide alone · 4 results
- Short-Term Effectiveness and Reduction in Insulin Requirements in Patients With Type 2 Diabetes Treated With IdegLira in a Real-World Setting.
Ramírez-Rincón A · Frontiers in endocrinology · 2022
Not a test of Liraglutide alone · 4 results
- Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.
Arrowaili A · Obesity surgery · 2025
Not a test of Liraglutide alone · 11 results
- New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov.
Alshehri FS · Medicine · 2025
Not a test of Liraglutide alone · 8 results
- Institutional experience on the impact of glucagon-like peptide-1 agonists (GLP-1) on glycemic control and weight loss in patients with type 2 diabetes at the Dubai Diabetes Center, United Arab Emirates.
Abdelmannan D · Diabetes research and clinical practice · 2024
Not a test of Liraglutide alone · 8 results
- Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Candido R · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
Not a test of Liraglutide alone · 4 results
- Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.
Ferrario MG · Primary care diabetes · 2016
Not a test of Liraglutide alone · 4 results
- Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used.
Norwood P · Diabetes, obesity & metabolism · 2017
Not a test of Liraglutide alone · 4 results
- A Descriptive Analysis from VigiAccess on Drug-related Problems Associated with the Glucagon-like Peptide-1 Receptor Agonists.
Amirthalingam P · Current drug safety · 2026
Not a test of Liraglutide alone · 18 results
- Comparation of fixed-ratio (IDegLira and iGlarLixi) versus free combination of basal insulin and glucagon-like peptide-1 receptor agonist for uncontrolled type 2 diabetes: A systematic review and network meta-analysis.
Weng J · Journal of evidence-based medicine · 2024
Not a test of Liraglutide alone · 4 results
- Comparative efficacy and safety of three fixed-ratio combination products in type 2 diabetes: A network meta-analysis.
Wang X · Journal of diabetes investigation · 2026
Not a test of Liraglutide alone · 4 results
- Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Obesity Without Diabetes.
Ali Akbar U · The American journal of cardiology · 2026
Not a test of Liraglutide alone · 12 results
- Glucagon-like peptide-1 receptor agonists in individuals with severe mental illness: A systematic review and meta-analysis of randomized controlled trials.
Srisurapanont M · International journal of psychiatry in medicine · 2026
Not a test of Liraglutide alone · 8 results
- Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.
Xu Y · Circulation · 2026
Not a test of Liraglutide alone · 8 results
- Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.
Monami M · Diabetes, obesity & metabolism · 2017
Not a test of Liraglutide alone · 6 results